Aerogen has been awarded a multi-year contract for Vizient’s Medication Delivery category, according to a company announcement.
Aerogen’s unique palladium vibrating mesh technology is their proprietary method of aerosol drug delivery and is a key component to all of their products.
The awarded contract will allow Aerogen to offer all Vizient members this premium solution as an option for their patients.
“Aerogen is looking forward to working with Vizient’s diverse membership and customer base, which includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks, and non-acute healthcare providers,” said Brant Nave, Vice President of Commercial Sales at Aerogen. “This partnership will help us continue our mission of improving patient outcomes and providing a premium customer experience.”
As the nation’s largest member-driven health care performance improvement company, Vizient provides network-powered insights in the critical areas of clinical, operational, and supply chain performance.
Vizient membership represents more than $130 billion in annual purchasing volume.
Beginning September 1, 2022, members will have the ability to purchase Aerogen products on contract with Vizient.
“We are excited to offer Vizient members the opportunity to buy our best-in class aerosol drug delivery technology with this agreement,” said John Power, Aerogen Founder & Chief Executive Officer. “Aerogen is dedicated to delivering world class customer service by continuing to provide timely solutions and build strong customer relationships.”
Source: Aerogen
